Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GH Guardant Health Inc.

盘后交易 03-23 17:23:30 EDT

84.96

-0.22

-0.26%

盘后84.96

+0.000.00%

16:52 EDT

最高88.32	最低84.71	成交量150.68万
今开87.56	昨收85.18	日振幅4.23%
总市值111.44亿	流通市值107.05亿	总股本1.31亿
成交额1.30亿	换手率1.20%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":84.96,"timestamp":1774296000000,"preClose":85.18,"halted":0,"volume":1506764,"hourTrading":{"tag":"盘后","latestPrice":84.96,"preClose":84.96,"latestTime":"16:52 EDT","volume":129614,"amount":11031215.53094,"timestamp":1774299140459,"change":0,"changeRate":0,"amplitude":0.003472},"delay":0,"changeRate":-0.0025827659074901745,"floatShares":126000000,"shares":131170441,"eps":-3.320281,"marketStatus":"盘后交易","change":-0.22,"latestTime":"03-23 17:23:30 EDT","open":87.56,"high":88.315,"low":84.71,"amount":129520574.58452,"amplitude":0.042322,"askPrice":86.62,"askSize":23,"bidPrice":84.1,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-3.320281,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774310400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":85.18,"preHourTrading":{"tag":"盘前","latestPrice":87.76,"preClose":85.18,"latestTime":"09:29 EDT","volume":818,"amount":70820.41954,"timestamp":1774272599999,"change":2.58,"changeRate":0.030289,"amplitude":0.066469},"postHourTrading":{"tag":"盘后","latestPrice":84.96,"preClose":84.96,"latestTime":"16:52 EDT","volume":129614,"amount":11031215.53094,"timestamp":1774299140459,"change":0,"changeRate":0,"amplitude":0.003472},"volumeRatio":0.943395,"impliedVol":0.6651,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/GH","defaultTab":"news","newsList":[{"id":"1160113114","title":"Guardant Health携手宏利在亚洲多市场推出Shield多癌种检测产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1160113114","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160113114?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:35","pubTimestamp":1773664512,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.与宏利达成合作，正式在亚洲多个市场推出其创新产品——Shield多癌种早期检测测试。\n此次合作标志着Guardant Health在扩大其癌症筛查技术全球可及性方面迈出重要一步。通过利用Guardant Health先进的液体活检技术，Shield测试旨在通过简单血液样本实现对多种癌症类型的早期筛查。\n这一举措有望为亚洲地区患者提供更便捷、高效的癌症早期检测方案，从而提升癌症防治水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4551","BK4196","BK4585","BK4535","GH"],"gpt_icon":0},{"id":"1120663348","title":"宏利金融与Guardant Health达成独家合作，将Shield多癌种早筛检测引入亚洲市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1120663348","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120663348?lang=zh_cn&edition=full","pubTime":"2026-03-16 11:01","pubTimestamp":1773630071,"startTime":"0","endTime":"0","summary":"宏利金融宣布与Guardant Health Inc.达成独家合作伙伴关系，双方将共同向亚洲地区客户推广Shield多癌种早期检测服务。此次合作旨在通过前沿的癌症筛查技术，为亚洲客户提供更全面的健康管理解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","GH","BK4196","BK4585","BK4551"],"gpt_icon":0},{"id":"1185436235","title":"财报前瞻｜Guardant Health Inc.营收预计强劲增长，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1185436235","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185436235?lang=zh_cn&edition=full","pubTime":"2026-02-12 10:24","pubTimestamp":1770863073,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.将于2026年02月19日发布业绩，市场共识预计营收延续高增，亏损率收窄，核心产品渗透扩大成看点。公司目前主营业务亮点在于肿瘤学检测业务，受益于Guardant360与TissueNext在医院端与生物制药客户渗透，带动流水扩大。来自机构的最新观点更偏向看多阵营，占比高于看空观点。某些华尔街机构指出，“随着生物制药合作订单的稳定落地与核心检测项目扩容，Guardant Health Inc.的收入增长确定性较强，若指引印证高增与费用纪律，股价具备进一步修复空间。”","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Guardant Health Inc.营收预计强劲增长，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"gpt_icon":0},{"id":"2609549637","title":"Guardant Health, Inc.涨2.82% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2609549637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609549637?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:35","pubTimestamp":1770388511,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时35分，Guardant Health, Inc.股票出现波动，股价快速拉升2.82%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.19%。其相关个股中，Ispecimen Inc.、Inotiv, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Xwell, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为91.58%、0.54%、0.19%，振幅较大的相关个股有Xwell, Inc.、Ispecimen Inc.、Check-Cap Ltd.，振幅分别为10.42%、10.29%、5.66%。Guardant Health, Inc.公司简介：总部位于加州红木城的Guardant Health是临床和研究用液体癌症检测的领导者。2021年，Guardant推出了Reveal，这是一种与肿瘤无关的分子残留疾病测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223511a6dc0cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223511a6dc0cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GH","BK4535","BK4551","BK4196","BK4588","BK4585"],"gpt_icon":0},{"id":"2606246128","title":"维升药业隆培生长激素获批：1年长高11厘米，百亿市场格局生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2606246128","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606246128?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:13","pubTimestamp":1769436796,"startTime":"0","endTime":"0","summary":"1月26日，国家药品监督管理局（NMPA）正式批准维升药业（2561.HK）的核心产品——隆培生长激素注射液上市，该产品用于治疗儿童生长激素缺乏症（PGHD）。这款每周注射一次的长效生长激素，是国内首个且唯一经三期临床试验证实，其疗效优于日制剂的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601263631011723.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601263631011723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4551","BK4585","BK4588","BK4196","GH","BK4535"],"gpt_icon":0},{"id":"1191355671","title":"Guardant Health公司Guardant360® Cdx获FDA批准 作为Braftovi®（Encorafenib）联合疗法在BRAF V600E突变转移性结直肠癌患者中的伴随诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=1191355671","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191355671?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:07","pubTimestamp":1769087239,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准Guardant Health公司旗下液体活检产品Guardant360 Cdx，将其作为Braftovi联合疗法用于BRAF V600E突变型转移性结直肠癌患者的伴随诊断工具。Guardant360 Cdx作为一种基于血液的检测方法，能够通过简单抽血即可识别出适合接受靶向治疗的患者群体，为传统组织活检提供了一种微创替代方案。此次获批意味着，临床医生现在可以依据该检测结果，为携带BRAF V600E突变的转移性结直肠癌患者制定包含Braftovi的个性化联合治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4196","BK4551","BK4585","BK4588","GH"],"gpt_icon":0},{"id":"1124929599","title":"Guardant Health与Trial Library达成合作，提升美国癌症临床试验的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1124929599","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124929599?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:06","pubTimestamp":1765458406,"startTime":"0","endTime":"0","summary":"Guardant Health与Trial Library达成合作，提升美国癌症临床试验的可及性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4196","GH","BK4551","BK4585"],"gpt_icon":0},{"id":"1176561683","title":"Guardant Health 拟发行 3 亿美元可转换高级票据，到期时间为2033年","url":"https://stock-news.laohu8.com/highlight/detail?id=1176561683","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176561683?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:40","pubTimestamp":1763570401,"startTime":"0","endTime":"0","summary":"Guardant Health Inc. :: Guardant Health 拟发行 3 亿美元的可转换高级票据，到期时间为2033年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","GH","BK4535","BK4196","BK4588"],"gpt_icon":0},{"id":"1140042890","title":"Guardant Health：肿瘤信号上升使疾病进展早至18个月，平均提前时间为2.3个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1140042890","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140042890?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:07","pubTimestamp":1762434465,"startTime":"0","endTime":"0","summary":"Guardant Health：肿瘤信号上升使疾病进展早至18个月，平均提前时间为2.3个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","GH","BK4588","BK4196","BK4535"],"gpt_icon":0},{"id":"1122589719","title":"Guardant Health：肿瘤信号减少超过98%的患者获得了显著益处","url":"https://stock-news.laohu8.com/highlight/detail?id=1122589719","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122589719?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:07","pubTimestamp":1762434460,"startTime":"0","endTime":"0","summary":"Guardant Health：肿瘤信号减少超过98%的患者获得了显著益处","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","BK4551","GH","BK4588","BK4585"],"gpt_icon":0},{"id":"1197091170","title":"异动解读 | Guardant Health股价盘中大跌8.77%，6.5亿美元融资计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1197091170","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197091170?lang=zh_cn&edition=full","pubTime":"2025-11-05 23:46","pubTimestamp":1762357612,"startTime":"0","endTime":"0","summary":"精准肿瘤学公司Guardant Health今日盘中大跌8.77%，延续了昨日夜间和今日盘前的跌势。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health于昨日收盘后宣布了一项重大融资计划。公司拟发行3亿美元的新股，同时还将非公开发行3.5亿美元、2033年到期的0%可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1145268630","title":"异动解读 | Guardant Health股价盘前大跌6.15%，新股发行和可转债计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1145268630","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145268630?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:46","pubTimestamp":1762336011,"startTime":"0","endTime":"0","summary":"周三盘前，精准肿瘤学公司Guardant Health股价大跌6.15%，延续了周二夜间交易时的跌势。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health于周二收盘后宣布了一项重大融资计划。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。值得注意的是，尽管短期内股价承压，但Guardant Health的长期表现仍然强劲。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1196560654","title":"异动解读 | Guardant Health夜盘大跌7.59%，新股和可转债发行计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1196560654","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196560654?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:15","pubTimestamp":1762305304,"startTime":"0","endTime":"0","summary":"精准肿瘤学公司Guardant Health在夜盘交易中股价大幅下跌7.59%，引发市场广泛关注。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health计划发行2.5亿美元的新股，同时非公开发行3亿美元、2033年到期的可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。尽管短期内股价承压，但Guardant Health的长期表现仍然强劲。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1129896298","title":"异动解读 | Guardant Health盘后大跌8.55%，拟发行新股和可转债","url":"https://stock-news.laohu8.com/highlight/detail?id=1129896298","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129896298?lang=zh_cn&edition=full","pubTime":"2025-11-05 06:32","pubTimestamp":1762295540,"startTime":"0","endTime":"0","summary":"周二盘后交易中，精准肿瘤学公司Guardant Health股价大幅下跌8.55%，引发投资者关注。据悉，Guardant Health宣布了一项重大融资计划。公司拟发行2.5亿美元的新股，同时还将非公开发行3亿美元2033年到期的可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。值得注意的是，Guardant Health目前已发行股票约1.26亿股，市值约124亿美元。尽管公司股价在盘后出现大幅下跌，但Guardant Health的长期表现依然强劲。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1137640606","title":"异动解读 | 盘中飙升27.45%，Guardant Health财报超预期提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1137640606","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137640606?lang=zh_cn&edition=full","pubTime":"2025-10-30 22:03","pubTimestamp":1761833006,"startTime":"0","endTime":"0","summary":"癌症检测公司Guardant Health周四盘中股价大涨27.45%，创下近期新高。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期，极大提振了投资者信心。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。受此利好消息影响，多家券商纷纷上调了Guardant Health的目标价。分析师普遍认为，Guardant Health在癌症液体活检技术领域的领先地位，以及其业务的持续改善，将为公司未来的增长提供强劲动力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1139818900","title":"异动解读 | 业绩超预期，Guardant Health盘前大涨20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139818900","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139818900?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:10","pubTimestamp":1761811821,"startTime":"0","endTime":"0","summary":"癌症检测公司Guardant Health Inc.周四盘前股价大涨20.73%，引发市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此外，Canaccord Genuity将公司的目标价从75美元上调至100美元，进一步提振了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":1},{"id":"1174423868","title":"异动解读 | 财报超预期，Guardant Health夜盘大涨21.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174423868","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174423868?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:30","pubTimestamp":1761784244,"startTime":"0","endTime":"0","summary":"周三夜盘，癌症检测公司Guardant Health Inc.股价大涨21.77%，引发市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此次超预期的财报结果不仅显示了公司业务的显著改善，也可能反映出其在癌症诊断领域的市场份额正在扩大。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":1},{"id":"1160061473","title":"异动解读 | 业绩超预期，Guardant Health盘后大涨11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160061473","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160061473?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:34","pubTimestamp":1761770042,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.今日盘后股价大涨11.11%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的第三季度财报优于市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，超过分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此次超预期的财报结果不仅显示了公司业务的强劲增长，也可能反映出其在癌症诊断领域的市场份额正在扩大。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1176722378","title":"Guardant Health 第三季度调整后每股亏损 USD -0.39，超出 IBES 预期 USD -0.76","url":"https://stock-news.laohu8.com/highlight/detail?id=1176722378","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176722378?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:26","pubTimestamp":1761769600,"startTime":"0","endTime":"0","summary":"10月29日 - Guardant Health 第三季度收入为 2.652 亿美元，而 IBES 预期为 2.357 亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4535","GH","BK4196","BK4585","BK4551"],"gpt_icon":0},{"id":"1153214292","title":"Guardant Health与Zephyr AI宣布合作，以解锁药物反应预测和生物标志物洞察","url":"https://stock-news.laohu8.com/highlight/detail?id=1153214292","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153214292?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:07","pubTimestamp":1761566829,"startTime":"0","endTime":"0","summary":"Guardant Health与Zephyr AI宣布合作，以解锁药物反应预测和生物标志物洞察","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","BK4588","BK4196","GH","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.207},{"period":"3month","weight":-0.146},{"period":"6month","weight":0.4401},{"period":"1year","weight":0.9047},{"period":"ytd","weight":-0.166}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Guardant Health, Inc.于2011年12月在特拉华州注册成立。该公司是一家领先的精密肿瘤学公司，致力于通过使用其专有血液测试，大量数据集和高级分析来帮助全球征服癌症。他们利用先进的血液和组织检测、真实世界数据和人工智能分析，提供关于疾病驱动因素的关键见解，从而变革患者护理。他们的检测有助于改善各个阶段的治疗效果，包括早期癌症筛查、早期癌症复发监测以及晚期癌症患者的治疗方案选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.03238},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.017651},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}